Machine learning identifies trauma patients benefiting from tranexamic acid treatment

Researchers from Osaka University use machine learning to identify patients more likely to survive traumatic injury if treated with tranexamic acid.

What to watch at ESMO: readouts from trials in lung, prostate, and other types of cancer

Europe’s major cancer research conference kicks off in Madrid on Friday, with headline — and potentially practice-changing — readouts from trials in lung, prostate, and

October 19, 2023

Chronic myeloid leukemia: Novartis survey signals need for better patient-physician communication

Only 19% to 26% of patients with chronic myeloid leukemia (CML) discuss treatment decisions with their physician, a survey by Swiss-based pharmaceutical Novartis has revealed.

June 9, 2023

Study reports the first local case of mpox caused by imported case in the Chinese mainland

Monkeypox (mpox) is a zoonotic disease caused by the mpox virus (MPXV) that has been primarily limited to Central and West African nations since its

July 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.